Yale, Connecticut Hospitals End Gender-Affirming Care for Minors Amid Federal Pressure

Yale New Haven Health and Connecticut Children’s Medical Center have announced they will stop providing gender-affirming medication treatments to patients under 19, citing pressure from the Trump Administration's federal executive orders banning federal support for such treatments for minors. Both institutions emphasized the difficult nature of this decision and committed to continuing mental health and other supportive services for affected patients. Connecticut Governor Ned Lamont and advocates expressed disappointment, highlighting that these federal mandates conflict with state values and have created fear and uncertainty among healthcare providers and families. Meanwhile, Boston Children’s Hospital has reaffirmed its commitment to providing gender-affirming care, condemning recent anti-trans legislation and promising to support transgender youth and their families. The Trump Administration’s policies have also influenced other university-affiliated hospitals, including the University of Chicago Medicine, to cease gender-affirming treatments for minors. This national trend reflects a broader conflict between federal policies and the medical community’s efforts to provide care for transgender youth.